OBJECTIVE: Antimicrobial susceptibility patterns across US pediatric healthcare institutions are unknown. A national pooled pediatric antibiogram (1) identifies nationwide trends in antimicrobial resistance, (2) allows across-hospital benchmarking, and (3) provides guidance for empirical antimicrobial regimens for institutions unable to generate pediatric antibiograms. METHODS: In January 2012, a request for submission of pediatric antibiograms between 2005 and 2011 was sent to 233 US hospitals. A summary antibiogram was compiled from participating institutions to generate proportions of antimicrobial susceptibility. Temporal and regional comparisons were evaluated using χ(2) tests and logistic regression, respectively. RESULTS: Of 200 institutions (85%) responding to our survey, 78 (39%) reported generating pediatric antibiograms, and 55 (71%) submitted antibiograms. Carbapenems had the highest activity against the majority of gram-negative organisms tested, but no antibiotic had more than 90% activity against Pseudomonas aeruginosa. Approximately 50% of all Staphylococcus aureus isolates were methicillin resistant. Western hospitals had significantly lower proportions of S. aureus that were methicillin resistant compared with all other regions tested. Overall, 21% of S. aureus isolates had resistance to clindamycin. Among Enterococcus faecium isolates, the prevalence of susceptibility to ampicillin (25%) and vancomycin (45%) was low but improved over time (P< .01), and 8% of E. faecium isolates were resistant to linezolid. Southern hospitals reported significantly higher prevalence of E. faecium with susceptibilities to ampicillin, vancomycin, and linezolid compared with the other 3 regions (P< .01). CONCLUSIONS: A pooled, pediatric antibiogram can identify nationwide antimicrobial resistance patterns for common pathogens and might serve as a useful tool for benchmarking resistance and informing national prescribing guidelines for children.
OBJECTIVE: Antimicrobial susceptibility patterns across US pediatric healthcare institutions are unknown. A national pooled pediatric antibiogram (1) identifies nationwide trends in antimicrobial resistance, (2) allows across-hospital benchmarking, and (3) provides guidance for empirical antimicrobial regimens for institutions unable to generate pediatric antibiograms. METHODS: In January 2012, a request for submission of pediatric antibiograms between 2005 and 2011 was sent to 233 US hospitals. A summary antibiogram was compiled from participating institutions to generate proportions of antimicrobial susceptibility. Temporal and regional comparisons were evaluated using χ(2) tests and logistic regression, respectively. RESULTS: Of 200 institutions (85%) responding to our survey, 78 (39%) reported generating pediatric antibiograms, and 55 (71%) submitted antibiograms. Carbapenems had the highest activity against the majority of gram-negative organisms tested, but no antibiotic had more than 90% activity against Pseudomonas aeruginosa. Approximately 50% of all Staphylococcus aureus isolates were methicillin resistant. Western hospitals had significantly lower proportions of S. aureus that were methicillin resistant compared with all other regions tested. Overall, 21% of S. aureus isolates had resistance to clindamycin. Among Enterococcus faecium isolates, the prevalence of susceptibility to ampicillin (25%) and vancomycin (45%) was low but improved over time (P< .01), and 8% of E. faecium isolates were resistant to linezolid. Southern hospitals reported significantly higher prevalence of E. faecium with susceptibilities to ampicillin, vancomycin, and linezolid compared with the other 3 regions (P< .01). CONCLUSIONS: A pooled, pediatric antibiogram can identify nationwide antimicrobial resistance patterns for common pathogens and might serve as a useful tool for benchmarking resistance and informing national prescribing guidelines for children.
Authors: Allan F Simpao; Luis M Ahumada; Beatriz Larru Martinez; Ana M Cardenas; Talene A Metjian; Kaede V Sullivan; Jorge A Gálvez; Bimal R Desai; Mohamed A Rehman; Jeffrey S Gerber Journal: Appl Clin Inform Date: 2018-01-17 Impact factor: 2.342
Authors: Sameer J Patel; Nicole Green; Sarah A Clock; David A Paul; Jeffrey M Perlman; Theoklis Zaoutis; Yu-Hui Ferng; Luis Alba; Haomiao Jia; Elaine L Larson; Lisa Saiman Journal: J Pediatric Infect Dis Soc Date: 2017-09-01 Impact factor: 3.164
Authors: Hannah C Neubauer; Matthew Hall; Michelle A Lopez; Andrea T Cruz; Mary Ann Queen; Dana M Foradori; Paul L Aronson; Jessica L Markham; Jennifer A Nead; Gabrielle Z Hester; Russell J McCulloh; Sowdhamini S Wallace Journal: J Hosp Med Date: 2021-03 Impact factor: 2.960
Authors: Hannah M Leeman; Benjamin P Chan; Carly R Zimmermann; Elizabeth A Talbot; Michael S Calderwood; Apara R Dave; Paul Santos; Katrina E Hansen Journal: Public Health Rep Date: 2021-03-05 Impact factor: 2.792